Advanced search
Publication Cover
Leukemia & Lymphoma Volume 19, 1995 - Issue 5-6
Submit an article Journal homepage
13
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Idarubicin in Combination with Cytarabine and VP-16 in the Treatment of post Myelodysplastic Syndrome Acute Myeloblastic Leukemia (MDS-AML)

E. M. Pogliani Institute of Internal Medicine, Hematology Department, University of Milano, S. Gerardo Hospital, Monza, Milano, Italy
,
L. Baldicchi Institute of Internal Medicine, Hematology Department, University of Milano, S. Gerardo Hospital, Monza, Milano, Italy
,
P. Pioltelli Institute of Internal Medicine, Hematology Department, University of Milano, S. Gerardo Hospital, Monza, Milano, Italy
,
I. R. Miccolis Institute of Internal Medicine, Hematology Department, University of Milano, S. Gerardo Hospital, Monza, Milano, Italy
,
M. Mangiagalli Institute of Internal Medicine, Hematology Department, University of Milano, S. Gerardo Hospital, Monza, Milano, Italy
&
G. M. Corneo Institute of Internal Medicine, Hematology Department, University of Milano, S. Gerardo Hospital, Monza, Milano, Italy
Pages 473-477 | Received 24 Dec 1994, Published online: 01 Jul 2009

References

  • Hussein K. K., Salem Z., Bottomley S., Livingstone R. Acute leukemia in idiopathic sideroblastic anemia: response to combination chemotherapy. Blood 1982; 59: 652–656
  • Murray C., Cooper B., Kitchens L. Remission of acute myelogenous leukemia in elderly patients with prior dysmyelopoietic anemia. Cancer 1983; 59: 967–970
  • Tricot G., Boogaerts M. The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes. Br. J. Haematol. 1986; 63: 477–483
  • Yunis J., Brunning R. Prognostic significance of chromosomal abnormalities in acute leukemias and myelodysplastic syndromes. Clin. Haematol. 1986; 15: 597–620
  • Hoyle C. F., De Bastos M., Wheatley K., et al. AML associated with previous cytotoxic chemotherapy. MDS or myelopro-liferative disorders: results from the MRC's 9th AML trial. Br. J. Haematol. 1989; 72: 45–53
  • Lazzarino M., Morra E., Alessandrino E. M., et al. Etoposide-cytarahine therapy for acute leukemia following myelodysplastic syndromes or secondary to treatment for malignant disease. Haematologica 1987; 72: 341–345
  • Martiat P., Ferrant A., Michaux J. L., Sokal G. Intensive chemotherapy for acute non-lymphoblastic leukemia after primary myelodysplastic syndrome. Haematol. Oncol. 1988; 6: 299–305
  • Gajewski J. L., Ho W. G., Nimer S. D., et al. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome. J. Clin. Oncol. 1989; 7: 1637–1645
  • Preisler H. D., Raza A., Barcos M., et al. High dose cytosine arabinoside as the initial treatment of poor risk patients with acute non-lymphocytic: leukemia. J. Clin. Oncol. 1987; 5: 72–82
  • Keating M. J., Smith T. L., Gehan E. A., et al. Factors related to length of complete remission in adult acute leukemia. Cancer 1980; 15: 2017–2029
  • Berman E., Raymand V., Gee T., Kempin S. J., Gulati G., Andreeff M. Idarubicin in acute leukemia: results of studies at Memorial Sloan Kettering Cancer Center. Semin. Oncol. 1989; 16 (suppl. 2): 30–34
  • Wiernick P. N., Case D. C., Jr, Perinan P. O., Arlin Z. A., Weitherg A. B., Ritch P. S. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult lymphoblastic leukemia. Semin. Oncol. 1989; 16(suppl. 2)25–29
  • Hamblin T. J. Intensive chemotherapy in myelodysplastic syndrome. Blood Reviews 1992; 6: 215–219
  • Toronto Study Group. Results of chemotherapy for unselected patients with acute myeloblastic leukemia: effect of exclusions on interpretation of results. Lancet 1986; i: 786–788
  • Sato H., Gottesman M. M., Goldstein L. J., et al. Expression of multidrug resistance gene in myeloid leukemias. Leuk. Res. 1990; 14: 11–21
  • Holmes J., Jacobs A., Carter G., Janowska-Weiezorek A., Padua R. Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes arid acute myelohlastic leukemia. Br. J. Haemat. 1989; 72: 40–44
  • Marie J-P., Zittoun R., Sikie B. I. Multidrug resistance (mdr1) gene ion in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78: 586–592
  • Berman E., McBride E. Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resis-tant leukemic cclls. Blood 1992; 79: 3267–3273
  • Lambertenghi G., Annaloro C., Cortelezzi A., Cortellaro M., Maiolo A. T., Pogliani E. M., Pozzoli E., Polli E. E. Idarubicin plus cytxrabine as first line treatment of acute non lymphoblastic leukemia. Semin. Oncol. 1989; 17 (suppl. 2): 16–21
  • Lambertenghi G., Pogliani E. M., Annaloro C. Therapeutic activity of idarubicin and cytarabine in patients with untreated acute non lymphoblastic leukemia. Proc. Am. Soc. Clin. Oncol. 1988; 7: 180
  • Casperssant T., De la Chapelle A., Schroder J. Quinacrine fluorescence of metaphase chromosomes. identical patterns in different tissue. Exp. Cell. Rev. 1972; 72: 56–59

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.